-
Walking Back From Cancer
An American expat in Norway describes how a favorite walking trail aided him during treatment and recovery.
by Steven Ford
-
Survivor Profile
Still in the GameESPN reporter Holly Rowe worked through melanoma treatment.
by Lindsey Konkel
-
Cancer and the Amish
A cancer survivor visits an Amish community and encounters resourcefulness in the face of the disease.
by Cynthia Ryan
-
In the Moment- Summer 2019
Readers share snapshots of their lives today.
-
What Not to Say to a Cancer Patient
When visiting a friend or family member who is sick, it's good to leave platitudes at the door.
by Michael Gavaghen
-
In the Moment- Spring 2019
Readers share snapshots of their lives today.
-
Survivor Profile
A Lesson in ServiceRabbi Ben David was comfortable in his role of helping those in need, but he had to rely on others after his lymphoma diagnosis. The marathon runner has returned to an active life one step at a time.
by Lindsey Konkel
-
In the Moment- Winter 2018/2019
Readers share snapshots of their lives today.
-
Survivor Profile
The Bridge BuilderBreast cancer survivor Bob Riter forges connections among people affected by all types of cancer.
by Marci A. Landsmann
-
Q&A
Dissecting Mental IllnessNeuroscientist Barbara Lipska describes her experiences with symptoms of psychiatric illness caused by treatment for metastases in her brain.
by Marci A. Landsmann
Cancer Talk
Screening Options for People With Dense Breasts
Reports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon